Cliantha Research Limited

Cliantha Research, full-service Clinical Research Organization (CRO), provides comprehensive and integrated offerings in Early Phase (BA-BE & Phase I), Late Phase (II-IV), Respiratory, Tobacco Research, Dermatology, Consumer Research, Research, Lab services, IVRT, Biometrics, Medical Services, Environmental Exposure Chambers (EECs).

Cliantha, by leveraging on the depth of experience provides ethical, value added customer centric services rooted in excellence, thereby enabling clinical development of pharmaceutical, biotech & healthcare companies.

With strategic acquisitions globally, Cliantha has widened the horizon of clinical research & support services for end-to-end developmental needs all across. The company merged its group companies Inflamax Research, Hilltop Research, and Solvius LLP under one flagship brand – Cliantha.

With several advanced clinical sites and bio-analytical laboratories in North America and India, Cliantha now has presence in 4 countries along with a strong team of 1000+ professionals. Some of the key regulators, such as the USFDA, EMA, AGES, ANSM, AMPS, MCC South Africa, Health Canada, DCGI, CAP, NABL, Turkey MOH, Thailand MoPH and others have successfully inspected Cliantha across the globe.

Cliantha Research is headquartered in Ahmedabad and has expanded its domestic reach with 5 regional offices & has presence in USA (Florida & New Jersey), Canada (Mississauga, Winnipeg & Scarborough) & Europe (Portugal)

Company’s Keywords:

pharmaceuticals, life sciences, clinical trials, central reference lab, dermatology, oncology, bioanalytical, immunochemistry, phase i, phase ii iv, clinical laboratory, biometrics, early phase, late phase, consumer research, data management, cdisc, biosimilars, ba be, respiratory, tobacco research